High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients
Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, Cristina Knape, Fleur M. Aung, Jamie Scroggins, Adriana Knopfelmacher, Victor Mulanovich, Jovan Borjan, Javier Adachi, Mayoora Muthu, Cerena Leung, Mayrin Correa Medina, Richard Champlin, Amanda Olson, Amin Alousi, Katayoun Rezvani, Elizabeth J. Shpall
doi: https://doi.org/10.1101/2021.03.08.21252775
Uri Greenbaum
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Kimberly Klein
2Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Fernando Martinez
2Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Juhee Song
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Peter F. Thall
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Jeremy L. Ramdial
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Cristina Knape
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Fleur M. Aung
2Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Jamie Scroggins
2Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Adriana Knopfelmacher
2Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Victor Mulanovich
4Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas
Jovan Borjan
5Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas
Javier Adachi
4Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas
Mayoora Muthu
6Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Cerena Leung
6Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Mayrin Correa Medina
2Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Richard Champlin
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Amanda Olson
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Amin Alousi
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Katayoun Rezvani
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
Elizabeth J. Shpall
1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Please contact the corresponding author for study dataset availability
Posted March 10, 2021.
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients
Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, Cristina Knape, Fleur M. Aung, Jamie Scroggins, Adriana Knopfelmacher, Victor Mulanovich, Jovan Borjan, Javier Adachi, Mayoora Muthu, Cerena Leung, Mayrin Correa Medina, Richard Champlin, Amanda Olson, Amin Alousi, Katayoun Rezvani, Elizabeth J. Shpall
medRxiv 2021.03.08.21252775; doi: https://doi.org/10.1101/2021.03.08.21252775
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients
Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, Cristina Knape, Fleur M. Aung, Jamie Scroggins, Adriana Knopfelmacher, Victor Mulanovich, Jovan Borjan, Javier Adachi, Mayoora Muthu, Cerena Leung, Mayrin Correa Medina, Richard Champlin, Amanda Olson, Amin Alousi, Katayoun Rezvani, Elizabeth J. Shpall
medRxiv 2021.03.08.21252775; doi: https://doi.org/10.1101/2021.03.08.21252775
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)